32 Leukemia Clinical Trials in Harrison, NY (2026)

Q: How do I join a clinical trial in Harrison?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Harrison research site will contact you.

Recruiting Leukemia Studies in Harrison

NCT03824483Recruiting

Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)

The purpose of this study is to determine the rate of minimum residual disease (MRD) negative response (i.e. the rate of no evidence of disease) of the study drugs, zanubrutinib, obinutuzumab, and ven...

Harrison, NYPHASE2230 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05967689Recruiting

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

The purpose of this study is to evaluate the safety, efficacy and pharmacokinetics (PK) of zipalertinib in participants with locally advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) harboring...

Harrison, NYPHASE2220 participantsTaiho Oncology, Inc.

View Study Details

NCT06033248Recruiting

Using Urine Samples to Identify Lung Cancer

The researchers are doing this study to test the ability of an animal biosensor platform (ABP) to detect NSCLC. Participants in this study will either be diagnosed with NSCLC, suspected to have NSCLC,...

Harrison, NY210 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05424029Recruiting

Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer

The purpose of this study is to find out if fluid rinsed from peoples' airways (bronchial washing samples) during routine surgery to remove (resect) their non-small cell lung cancer (NSCLC) tumors con...

Harrison, NY200 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06698003Recruiting

A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

The purpose of this study is to find out whether the study drug mogamulizumab is effective in preventing the development of adult T-cell leukemia/lymphoma (ATL) in people who are at higher risk for th...

Harrison, NYPHASE2134 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07690917Recruiting

A Study of a New PET Scanner in People With Cancer

The researchers are doing this study to test the capabilities of a new total-body PET scanner called the Biograph Vision Quadra. The researchers want to learn whether this scanner can produce better P...

Harrison, NY90 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT01639508Recruiting

Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

The purpose of this phase II study is to find out what effects cabozantinib (XL184) has, good and/or bad, in patients whose tumors one of the following gene changes RET, ROS1, or NTRK fusion, or incre...

Harrison, NYPHASE286 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06561360Recruiting

A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People with Hairy Cell Leukemia (HCL)

The researchers are doing this study to compare the safety of vemurafenib in combination with obinutuzumab to the standard of approach of cladribine in combination with rituximab. The researchers will...

Harrison, NYPHASE286 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06957314Recruiting

A Study of Hospital-at-Home for People Receiving Tarlatamab

The purpose of this study is to find out whether a Hospital-at-Home (HaH) program is a more efficient way to monitor people's health after receiving tarlatamab than monitoring in the hospital (inpatie...

Harrison, NYNA70 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05657873Recruiting

A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

The purpose of this study is to see whether adding liver stereotactic ablative radiotherapy/L-SABR to standard drug therapy is better than standard drug therapy alone for people with metastatic non-sm...

Harrison, NYPHASE268 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07535437Recruiting

A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer

The researchers are doing this study to find out whether ivonescimab in combination with datopotamab deruxtecan- (Dato-DXd) or osimertinib are safe and effective treatments in people with non-small ce...

Harrison, NYPHASE166 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07052916Recruiting

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

Research has shown that music-based activities may help improve brain functions, such as attention, memory, and executive function. Because of this past research, the researchers are doing this study ...

Harrison, NYNA60 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07218601Recruiting

Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer

The researchers are doing this study to test the ability of a new technology called breathprinting, or electronic nose (E-Nose), to measure changes in certain chemicals in the breath before and after ...

Harrison, NYPHASE260 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07535463Recruiting

A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer

The researchers are doing this study to test the safety of ivonescimab given in combination with standard chemotherapy and stereotactic radiosurgery (SRS) in people with non-small cell lung cancer (NS...

Harrison, NYPHASE153 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07356154Recruiting

A Study of Revumenib and Mezigdomide in People With Leukemia

The purpose of this study is to find out whether the combination of mezigdomide and revumenib is a safe treatment for people with relapsed or refractory KMT2A-r, NUP98-r, and NPM1-m acute leukemias....

Harrison, NYPHASE152 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07392242Recruiting

A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

The researchers are doing this study to find out whether a 3-drug combination of ivosidenib, azacitidine, and venetoclax followed by maintenance therapy with ivosidenib alone is an effective treatment...

Harrison, NYPHASE245 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05748197Recruiting

A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

The purpose of this study is to test the safety of ADCLEC.syn1 CAR T cells in people with relapsed or refractory AML. The researchers will try to find the highest dose of ADCLEC.syn1 CAR T cells that ...

Harrison, NYPHASE140 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07400029Recruiting

A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia

The researchers are doing this study to find out whether obecabtagene autoleucel (obe-cel) is an effective treatment for people with B-cell acute lymphoblastic leukemia (ALL) that is in complete remis...

Harrison, NYPHASE240 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06582771Recruiting

A Study of Sotorasib in People with Non-Small Cell Lung Cancer

The researchers are doing this study to see if sotorasib is a safe and effective treatment for people with advanced non-small cell lung cancer (NSCLC) with a KRAS G12C mutation who have not received t...

Harrison, NYPHASE239 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07594522Recruiting

A Study of Ivonescimab in People With Non-Small Cell Lung Cancer

The researchers are doing this study to find out whether ivonescimab after receiving standard stereotactic body radiotherapy (SBRT) is an effective treatment in people with Non-Small Cell Lung Cancer ...

Harrison, NYPHASE136 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT04301076Recruiting

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

This phase I trial studies the side effects and best dose of lenalidomide when given together with usual combination chemotherapy (etoposide, prednisone, vincristine sulfate \[Oncovin\], cyclophospham...

Harrison, NYPHASE130 participantsNational Cancer Institute (NCI)

View Study Details

NCT06773208Recruiting

A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

The purpose of this study is to find out if azacitidine and venetoclax are an effective treatment approach to get rid of or lower measurable residual disease (MRD) in people with acute myeloid leukemi...

Harrison, NYPHASE230 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06807632Recruiting

A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer

This study will test whether valemetostat in combination with atezolizumab is a safe treatment that causes few or mild side effects in people with extensive-stage small cell lung cancer (SCLC). The re...

Harrison, NYPHASE124 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07661095Recruiting

A Study of CRD3874-SI in People With Leukemia

The purpose of this study is to find out whether CRD3874-SI is a safe treatment for participants with acute myeloid leukemia (AML)....

Harrison, NYPHASE124 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05756777Recruiting

A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

The researchers are doing this study to see if the combination of gilteritinib with ivosidenib or enasidenib is a safe and effective treatment for people with relapsed/refractory AML with FLT3/IDH1 or...

Harrison, NYPHASE118 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05985148Recruiting

A Study of Stereotactic Radiosurgery (SRS) to Treat Pain in the Chest and/or Stomach Wall

The researchers are doing this study to find out whether stereotactic radiosurgery (SRS) is a safe, practical (feasible), and effective treatment for people with chronic TAWP. The researchers will tes...

Harrison, NYPHASE118 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07011004Recruiting

A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

The researchers are doing this study is to find the highest dose of cytokine-induced memory-like (CIML) natural killer (NK) cells in combination with the drug atezolizumab that causes few or mild side...

Harrison, NYPHASE118 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06287528Recruiting

A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)

Participants will have a sample of their white blood cells, called T cells, collected using a procedure called leukapheresis. The collected T cells will be sent to a laboratory to be changed (modified...

Harrison, NYPHASE118 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07619339Recruiting

A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer

The researchers are doing this study to find out whether the combination of tepotinib and ivonescimab is a safe and effective treatment for people with non-small cell lung cancer (NSCLC) that is posit...

Harrison, NYPHASE116 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06017258Recruiting

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

The purpose of this study is to find out whether CD371-YSNVZ-IL18 CAR T cells are safe, and to look for the highest dose of CD371-YSNVZ-IL18 CAR T cells that cause few or mild side effects in particip...

Harrison, NYPHASE115 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07428044Recruiting

A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

The purpose of this study is to find out how many people with HER2-amplified or HER2-mutated non-small cell lung cancer (NSCLC) experience a decrease in tumor viability when they receive trastuzumab d...

Harrison, NYPHASE214 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT04512716Recruiting

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

This is a pilot study; patients will receive 131-I apamistamab prior to CAR T-cell infusion in order to determine the maximum tolerated dose of 131-I apamistamab is exceeded at 75 mCi, and if so, to a...

Harrison, NYEARLY_PHASE112 participantsMemorial Sloan Kettering Cancer Center

View Study Details

About Leukemia Clinical Trials in Harrison

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 32 leukemia clinical trials recruiting participants in Harrison, NY. These studies are seeking a combined 2,122 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center, Taiho Oncology, Inc., National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Harrison — FAQ

Are there leukemia clinical trials in Harrison?

Yes, there are 32 leukemia clinical trials currently recruiting in Harrison, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Harrison?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Harrison research site will contact you about next steps.

Are clinical trials in Harrison free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Harrison studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 32 active trials in Harrison are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated July 20, 2026 from ClinicalTrials.gov